BioPharmX Corp·4

Sep 11, 7:51 PM ET

Krammer Anja B 4

4 · BioPharmX Corp · Filed Sep 11, 2018

Insider Transaction Report

Form 4
Period: 2018-09-10
Krammer Anja B
DirectorPresident10% Owner
Transactions
  • Award

    Option to purchase common stock

    2018-09-10+1,042,0001,042,000 total
    Exercise: $0.20Exp: 2028-09-10Common stock (1,042,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable ratably over 36 months.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT